Treatment with arimoclomol, an HSP amplifier, additionally decreased lysosomal storage in NPC patient fibroblasts and neurological symptoms in Npc1−/− mice, thereby prompting us to further investigate the roles of HSP amplification in ameliorating the defective myelination observed within the CNS in NPC. Here, HSP90B2P is linked to nasopharyngeal carcinoma.